New Amsterdam Exit: Anupam Kher Not Returning as Dr. Vijay Kapoor

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

One of New Amsterdam‘s docs is hanging up his white coat: Anupam Kher, who played Dr. Vijay Kapoor, will not return to the NBC medical drama, TVLine has confirmed.

In the April 13 episode, Dr. Iggy Frome found out that his colleague Dr. Kapoor had resigned from the hospital after a battle with COVID, open-heart surgery and then a difficult rehab process that left him unable to resume his job. Viewers last saw Dr. Kapoor at the beginning of Season 3, when he was fighting for his life. (Although Dr. Kapoor was infected with COVID, the show actually cannibalized footage from its unaired Season 2 influenza pandemic episode, in which Dr. Kapoor caught the flu.)

More from TVLine

Kher had been a series regular on New Amsterdam since its debut in 2018, playing the head of the neurology department. In real life, the actor’s wife, actress Kirron Kher, has been undergoing treatment for blood cancer, The Hindustan Times reports.

“She is currently undergoing treatment and we are sure she will come out of this stronger than before. We are very blessed that she is being looked after by a phenomenal set of doctors,” Anupam Kher said in a statement to The Hindustan Times, adding that Kirron is “well on her way to recovery and we thank everyone for their support and love.”

UPDATE: Kher released the following statement via Instagram on April 27: “This past year has been difficult for so many people around the world, not least for Dr. Kapoor. It was an incredibly special time for me to be part of this show and one I will never forget. The New Amsterdam family will always hold a special place in my heart. I am grateful to the audience for their love, support, and good wishes, particularly for my wife, Kirron, at this time. I hope you all will continue to join me on my journey and future projects.”

Best of TVLine

Get more from TVLine.com: Follow us on Twitter, Facebook, Newsletter